On May 11, the Israeli Supreme Court handed down its long-awaited ruling in the case known as the “Assuta Embryo Mix-Up.” The case has drawn widespread attention in Israel and abroad — not just because…
Developments in neurotechnologies, which interface with one’s nervous system to monitor, stimulate, or modulate neural activity in the brain, are progressing at a rapid rate.
The U.S. government’s reliance on the most-favored-nation (MFN) pricing model — tying drug costs to the lowest price paid by other countries — is a politically appealing but structurally flawed solution.
Antimicrobial resistance (AMR) is a growing global health threat, but its impact is particularly severe in Africa, where resistance infection rates and death are highest.
On April 2, 2025 the Brazilian Supreme Court decided that strip searches of prison visitors were unconstitutional except in “exceptional circumstances.” The decision is one step in the direction of reducing the mental and physical…
After Part 1 of this series was published, 23andMe dropped its bid for an independent customer data representative and agreed to the appointment of a privacy ombudsman.
The Global Health and Rights Project (GHRP) welcomes four affiliated researchers from Argentina for academic year 2025-26.
Former Petrie-Flom Fellow-in-Residence Elizabeth Chloe Romanis recently published her latest book, Biotechnology, Gestation, and the Law, with Oxford University Press. Here, we catch up with Chloe to ask her about the book and its key…
In this piece, we draw on insights about the complementary nature of human and AI intelligence to identify three key lessons for effectively integrating AI into health care practice and policy, using examples from recent…
Even with so many major headlines competing for attention last month, it was hard to miss the news that 23andMe had filed for bankruptcy.
